Literature DB >> 1800630

The large-scale isolation of bryostatin 1 from Bugula neritina following current good manufacturing practices.

D E Schaufelberger1, M P Koleck, J A Beutler, A M Vatakis, A B Alvarado, P Andrews, L V Marzo, G M Muschik, J Roach, J T Ross.   

Abstract

A novel process was designed for the large-scale isolation of bryostatin 1 from the bryozoan Bugula neritina L. in order to obtain multigram quantities of highly pure material for formulation studies, preclinical toxicology, and clinical trials in cancer patients. Multigram quantities of bryostatin 1 were obtained from a collection of approximately 10,000 gallons of wet animal. A phorbol dibutyrate (PDBu) receptor binding assay and hplc with photodiode array detection were used for the design, validation, and control of the isolation process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1800630     DOI: 10.1021/np50077a004

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  48 in total

1.  Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis.

Authors:  Paul A Wender; Brian A Loy; Adam J Schrier
Journal:  Isr J Chem       Date:  2011-03-24       Impact factor: 3.333

Review 2.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

3.  The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinity.

Authors:  Paul A Wender; Vishal A Verma
Journal:  Org Lett       Date:  2008-06-28       Impact factor: 6.005

4.  Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity.

Authors:  Paul A Wender; Jeremy L Baryza; Stacey E Brenner; Brian A DeChristopher; Brian A Loy; Adam J Schrier; Vishal A Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

5.  How Might We Cure HIV?

Authors:  David M Margolis
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

Review 6.  Leveraging synthetic biology for producing bioactive polyketides and non-ribosomal peptides in bacterial heterologous hosts.

Authors:  Taylor B Cook; Brian F Pfleger
Journal:  Medchemcomm       Date:  2019-04-25       Impact factor: 3.597

Review 7.  Conformation-activity relationships of polyketide natural products.

Authors:  Erik M Larsen; Matthew R Wilson; Richard E Taylor
Journal:  Nat Prod Rep       Date:  2015-08       Impact factor: 13.423

8.  Nature's bounty - drug discovery from the sea.

Authors:  John J Bowling; Anna J Kochanowska; Noer Kasanah; Mark T Hamann
Journal:  Expert Opin Drug Discov       Date:  2007-11       Impact factor: 6.098

Review 9.  Emerging strategies to deplete the HIV reservoir.

Authors:  Nancie M Archin; David M Margolis
Journal:  Curr Opin Infect Dis       Date:  2014-02       Impact factor: 4.915

10.  Culture of explants from the sponge Mycale cecilia to obtain bioactive mycalazal-type metabolites.

Authors:  Jose L Carballo; Benjamin Yañez; Eva Zubía; Maria J Ortega; Cristina Vega
Journal:  Mar Biotechnol (NY)       Date:  2009-11-26       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.